icon-folder.gif   Conference Reports for NATAP  
  EASL 2024
June 5-8, Milan, Italy
Back grey_arrow_rt.gif
Modeling suggests that undetectable HCV at week 2 of DAA
therapy could identify patients for shorter treatment duration

  EASL 2024 June 5-8
Written by Jules Levin
Ashish Goyal1, Ohad Etzion2, Kimberly Page3, Tatyana Kushner4, Yedidya Saiman5, Scott Cotler1, Harel Dahari1.